Intraocular Lens Injectors Market Analysis

  • Report ID: 6032
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Intraocular Lens Injectors Segmentation

Product Type (Preloaded, Single Use, Reusable, High Diopter Intraocular Lens)

Preloaded intraocular lens injectors segment is poised to dominate over 40% intraocular lens injectors market share by 2037. This growth of the segment is set to be encouraged by growing cases of contamination by manual systems. Preloaded intraocular lens injectors reduce the possibility of endophthalmitis contamination.

Recently a study was conducted which stated that microbial causes from the prevalence of endophthalmitis are gram-positive bacteria which account for 85.1% of all isolates, whereas gram-negative bacteria accounted for 10.3% prevalence, and 4.6% of all cases were caused owing to fungi. Furthermore, it also reduces the prevalence of mistakes including loading the lens incorrectly.

Moreover, it has proven its efficiency to the nursing or technical staff by reducing the need to load the lenses, along with the surgeon. Also, it enables surgeons to preload several lenses and additionally limits the prevalence of delay once the lens is chosen. 

Technology Type (Manual, Electric)

By 2037, electric segment is estimated to dominate over 3.05% intraocular lens injectors market share. The major factor for the expansion of the segment is rising investment in digitalization in the healthcare sector. According to the World Bank over the past decade has spent over USD 4 billion on digital health which includes digital governance, infrastructure, and more.

Furthermore, the number of startups has successfully grown all across the world which is further offering digital health products for the patients. As a result, the electric segment of the intraocular lens injectors market is expected to observe growth.

Application (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Eye Research Institutes)

In intraocular lens injectors market, hospitals segment is poised to dominate over 49% revenue share by 2037. Various key players along with the government are also initiating the construction of advanced hospitals with the latest medical technologies further providing insurance coverage. This is leading to an increase in the number of hospitals with advanced technologies, for instance, in the year 2021, the globe had about 164,000 hospitals.

Our in-depth analysis of the global intraocular lens injectors market includes the following segments:

 

 

 

          Product Type

  • Preloaded Intraocular Lens Injectors
  • Single Use Intraocular Lens Injectors
  • Reusable Intraocular Lens Injectors
  • High Diopter Intraocular Lens

 

          Technology Type

  • Manual
  • Electric

 

 

          Tip Incision Size

  • 1.8mm
  • 2.0mm
  • 2.2mm
  • 2.4mm
  • 2.6mm

 

 

          Application

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
  • Eye Research Institutes

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intraocular lens injectors is assessed at USD 17.16 billion.

The intraocular lens injectors market size was over USD 16.43 billion in 2024 and is projected to reach USD 31.76 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growing prevalence of cataracts.

North America industry is poised to account for largest revenue share of 30% by 2037, influenced by growing prevalence ophthalmic disorders in the region.

The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos